BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Naqvi SMH, Gala MYN, Muchhala S, Arumugam A, Panigrahi D, Patil D, Rathod R, Mane A. Pharmacokinetics/Pharmacodynamics study of Fixtral SB as compared to supra bioavailable itraconazole and conventional itraconazole. World J Pharmacol 2023; 12(1): 1-11 [DOI: 10.5497/wjp.v12.i1.1]
URL: https://www.wjgnet.com/2220-3192/full/v12/i1/1.htm
Number Citing Articles
1
Dhiraj Dhoot. Open-Label Crossover Oral Bioequivalence Pharmacokinetics Comparison of a Single Dose of Super-bioavailable Itraconazole 130 mg and Innovator SUBA®-Itraconazole Capsules 130 mg (2 x 65 mg) in Healthy Adults Under Fed ConditionsJournal of Dermatology Research 2024; : 1 doi: 10.46889/JDR.2024.5204